A review of clozapine safety
- PMID: 16011451
- DOI: 10.1517/14740338.4.4.731
A review of clozapine safety
Abstract
Clozapine is a distinctive antipsychotic agent, having a unique clinical profile and an idiosyncratic safety profile. More so than with other agents, the weighting of its adverse event profile is critical, in order to counterbalance its clear clinical advantages. The safety issues with clozapine are in a number of areas, some of which are considered medical emergencies and potentially life-threatening. These include haematological (neutropenia and agranulocytosis), CNS (seizures), cardiovascular (myocarditis and cardiomyopathy), metabolic (diabetes), gastrointestinal and neuromuscular. Understanding the safety profile of clozapine allows an informed use of the agent that can maximise its clear clinical benefit and minimise the known risks.
Similar articles
-
[Reaction on 'Myocarditis and cardiomyopathy underestimated complications resulting from clozapine therapy'].Tijdschr Psychiatr. 2011;53(3):193-4. Tijdschr Psychiatr. 2011. PMID: 21404176 Dutch. No abstract available.
-
[Myocarditis and cardiomyopathy: underestimated complications resulting from clozapine therapy].Tijdschr Psychiatr. 2010;52(4):223-33. Tijdschr Psychiatr. 2010. PMID: 20503163 Review. Dutch.
-
Early recognition of clozapine-induced myocarditis.J Clin Psychopharmacol. 2007 Oct;27(5):479-83. doi: 10.1097/jcp.0b013e31814e5e68. J Clin Psychopharmacol. 2007. PMID: 17873680
-
Monitoring the safe use of clozapine: a consensus view from Victoria, Australia.CNS Drugs. 2007;21(2):117-27. doi: 10.2165/00023210-200721020-00003. CNS Drugs. 2007. PMID: 17284094 Review.
-
Repeated occurrence of clozapine-induced myocarditis in a patient with schizoaffective disorder and comorbid Parkinson's disease.Neuro Endocrinol Lett. 2009 Mar;30(1):19-21. Neuro Endocrinol Lett. 2009. PMID: 19300384
Cited by
-
Clozapine augmentation strategies.Ment Health Clin. 2019 Nov 27;9(6):336-348. doi: 10.9740/mhc.2019.11.336. eCollection 2019 Nov. Ment Health Clin. 2019. PMID: 31857930 Free PMC article.
-
Continuing clozapine treatment with lithium in schizophrenic patients with neutropenia or leukopenia: brief review of literature with case reports.Ther Adv Psychopharmacol. 2016 Feb;6(1):33-8. doi: 10.1177/2045125315624063. Ther Adv Psychopharmacol. 2016. PMID: 26913176 Free PMC article. Review.
-
Adverse Drug Reactions in Relation to Clozapine Plasma Levels: A Systematic Review.Pharmaceuticals (Basel). 2022 Jul 1;15(7):817. doi: 10.3390/ph15070817. Pharmaceuticals (Basel). 2022. PMID: 35890117 Free PMC article. Review.
-
Improving the Monitoring and Management of Clozapine-Induced Gastrointestinal Hypomotility (CIGH) in Community Mental Health Services: A Quality Improvement Approach.Pharmacy (Basel). 2024 Sep 13;12(5):141. doi: 10.3390/pharmacy12050141. Pharmacy (Basel). 2024. PMID: 39311132 Free PMC article.
-
Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis.CNS Drugs. 2015 Jul;29(7):591-603. doi: 10.1007/s40263-015-0262-y. CNS Drugs. 2015. PMID: 26242478
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources